NSPR - InspireMD - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NSPR is currently covered by 1 analysts with an average price target of $4.65. This is a potential upside of $2.21 (90.57%) from yesterday's end of day stock price of $2.44.

InspireMD's activity chart (see below) currently has 9 price targets and 8 ratings on display. The stock rating distribution of NSPR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.5% with an average time for these price targets to be met of 63 days.

Highest price target for NSPR is $4, Lowest price target is $4, average price target is $4.

Most recent stock forecast was given by ADAM MAEDER from PIPER SANDLER on 12-May-2025. First documented stock forecast 16-Oct-2020.

Best performing analysts who are covering NSPR - InspireMD:

Ben Haynor Adam Maeder

Currently out of the existing stock ratings of NSPR, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$4

$1.61 (67.36%)

$4.5

2 months 13 days ago
(12-May-2025)

1/4 (25%)

$1.42 (55.04%)

30

Buy

$4.75

$2.36 (98.74%)

$5.15

2 years 2 months 8 days ago
(17-May-2023)

1/5 (20%)

$2.99 (169.89%)

96

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NSPR (InspireMD) average time for price targets to be met?

On average it took 63 days on average for the stock forecasts to be realized with a an average price target met ratio 22.5

Which analyst has the current highest performing score on NSPR (InspireMD) with a proven track record?

BEN HAYNOR

Which analyst has the current lower performing score on NSPR (InspireMD) with a proven track record?

ADAM MAEDER

Which analyst has the most public recommendations on NSPR (InspireMD)?

Ben Haynor works at LAKE STREET and has 17 price targets and 9 ratings on NSPR

Which analyst is the currently most bullish on NSPR (InspireMD)?

Ben Haynor with highest potential upside - $2.36

Which analyst is the currently most reserved on NSPR (InspireMD)?

Adam Maeder with lowest potential downside - $1.61

InspireMD in the News

InspireMD Reports First Quarter 2025 Financial Results

MIAMI, May 09, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced financial and operating results for the first quarter ended March 31, 2025. BusinessHighlights: Continued engagement with the U.S. Food and Drug Administration (FDA)...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?